After the prolonged wait and conflicting signals, the World Health Organization’s approval for the indigenous Covid-19 vaccine, Covaxin, brings much-needed relief and reflects global acknowledgement of India’s scientific prowess and research credentials. More importantly, it paves the way for its widespread distribution around the world and brightens the chances for the company’s vaccine for children […]
"Vaccine manufacturers in the city were sending every batch for testing to the national vaccine testing centre in Kasauli and this was resulting in loss of 45 days of valuable time," the Minister said
“I think our preliminary assessment indicates that vaccines will require a dedicated manufacturing facility and it cannot be produced in a facility where we are making multiple other products,” the company MD said
"The US administration must immediately deploy supplies that are urgently required in India to augment the vaccine production to continue without any interruption," said IACC's National President.